Dirk Steinritz Selected Research

Mustard Gas (Sulfur Mustard)

1/2022	Transthyretin as a target of alkylation and a potential biomarker for sulfur mustard poisoning: Electrophoretic and mass spectrometric identification and characterization.
1/2021	Chronic senescent human mesenchymal stem cells as possible contributor to the wound healing disorder after exposure to the alkylating agent sulfur mustard.
9/2019	Evaluation of selective and non-selective cyclooxygenase inhibitors on sulfur mustard-induced pro-inflammatory cytokine formation in normal human epidermal keratinocytes.
9/2018	Anti-apoptotic and moderate anti-inflammatory effects of berberine in sulfur mustard exposed keratinocytes.
9/2018	Mobilization of human mesenchymal stem cells through different cytokines and growth factors after their immobilization by sulfur mustard.
9/2018	Accidental sulfur mustard exposure: A case report.
1/2018	Immediate responses of the cockroach Blaptica dubia after the exposure to sulfur mustard.
5/2016	Impairment of hypoxia-induced HIF-1α signaling in keratinocytes and fibroblasts by sulfur mustard is counteracted by a selective PHD-2 inhibitor.
2/2016	Upregulation of miR-203 and miR-210 affect growth and differentiation of keratinocytes after exposure to sulfur mustard in normoxia and hypoxia.
2/2016	Protective effects of the thiol compounds GSH and NAC against sulfur mustard toxicity in a human keratinocyte cell line.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dirk Steinritz Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 02/2011
10	Poisoning 01/2022 - 09/2011
8	Blister (Bulla) 01/2022 - 12/2010
5	Wounds and Injuries (Trauma) 01/2021 - 12/2013
5	Inflammation (Inflammations) 09/2018 - 09/2009
4	Erythema 10/2019 - 01/2018
4	Necrosis 09/2018 - 12/2013
3	Edema (Dropsy) 11/2017 - 06/2007
2	Hypoxia (Hypoxemia) 05/2016 - 02/2016
2	Heart Failure 10/2006 - 08/2006
1	Ulcer 01/2021
1	Hyperpigmentation 02/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Disease Progression 09/2018
1	Long Term Adverse Effects 09/2018
1	Ganglion Cysts (Ganglion) 01/2018
1	Asthma (Bronchial Asthma) 11/2017
1	Fibrosis (Cirrhosis) 11/2017
1	Pneumonia (Pneumonitis) 11/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2017
1	Pain (Aches) 05/2017
1	Carcinogenesis 02/2016
1	Sialorrhea 02/2016
1	Hypotension (Low Blood Pressure) 02/2016
1	Bradycardia 02/2016
1	Genomic Instability 02/2016
1	Miosis 02/2016
1	Lung Injury 01/2013
1	Respiratory Insufficiency (Respiratory Failure) 09/2007
1	Acute Lung Injury 06/2007
1	Hemorrhage 06/2007
1	Erectile Dysfunction 03/2006

Drug/Important Bio-Agent (IBA)

16	Mustard Gas (Sulfur Mustard)IBA 01/2022 - 06/2007
7	Chemical Warfare AgentsIBA 11/2019 - 12/2010
4	Alkylating AgentsIBA 01/2021 - 09/2009
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2018
3	Pharmaceutical PreparationsIBA 01/2022 - 02/2016
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2018
2	AlbuminsIBA 01/2021 - 02/2016
2	Therapeutic UsesIBA 09/2020 - 09/2018
2	Silybin (Lagosa)IBA 09/2020 - 12/2013
2	PesticidesIBA 07/2020 - 09/2011
2	Irritants (Vesicants)IBA 10/2019 - 12/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2011
2	Interleukin-6 (Interleukin 6)IBA 09/2018 - 02/2016
2	Oxygen (Dioxygen)IBA 05/2016 - 10/2006
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2016 - 02/2016
2	Obidoxime Chloride (Obidoxime)IBA 02/2016 - 09/2011
2	Atropine FDA LinkGeneric 09/2011 - 09/2007
1	Prealbumin (Transthyretin)IBA 01/2022
1	englerin AIBA 01/2022
1	navitoclaxIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Organic Anion TransportersIBA 09/2020
1	AmanitinsIBA 09/2020
1	Melanins (Melanin)IBA 02/2020
1	AcidsIBA 01/2020
1	bardoxolone methylIBA 01/2020
1	TriterpenesIBA 01/2020
1	EstersIBA 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	SmokeIBA 09/2018
1	CarcinogensIBA 09/2018
1	Ibuprofen (Motrin)FDA LinkGeneric 09/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2018
1	GlucocorticoidsIBA 09/2018
1	Adenylate KinaseIBA 09/2018
1	Diclofenac (SR 38)FDA LinkGeneric 09/2018
1	Cytostatic AgentsIBA 09/2018
1	MicroRNAs (MicroRNA)IBA 09/2018
1	TRPC6 Cation ChannelIBA 11/2017
1	AnkyrinsIBA 05/2017
1	TRPA1 Cation ChannelIBA 05/2017
1	Hypoxia-Inducible Factor 1IBA 05/2016
1	Transcription Factors (Transcription Factor)IBA 05/2016
1	OligonucleotidesIBA 02/2016
1	4-(2-oxapentadeca-4-yne)phenylpropanoic acidIBA 02/2016
1	methamidophosIBA 02/2016
1	Keratin-1IBA 02/2016
1	Cholinergic Agents (Cholinergics)IBA 02/2016
1	LyasesIBA 02/2016
1	AcetylcholinesteraseIBA 02/2016
1	2-chloroethyl ethyl sulfideIBA 12/2013
1	Nucleosomes (Nucleosome)IBA 12/2013
1	AntidotesIBA 12/2013
1	Blood Proteins (Serum Proteins)IBA 03/2013
1	OrganophosphatesIBA 09/2011
1	NitrogenIBA 09/2009
1	Free RadicalsIBA 10/2006
1	sapropterin (tetrahydrobiopterin)FDA Link 03/2006

Therapy/Procedure

6	Therapeutics 11/2019 - 08/2006
1	Radiotherapy 01/2020
1	Drug Therapy (Chemotherapy) 02/2016